FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4205865051> ?p ?o ?g. }

• W4205865051 endingPage "e402" @default.
• W4205865051 startingPage "e393" @default.
• W4205865051 abstract "The purpose of this study was to determine the clinical and chondroprotective efficacy and safety of orally administered Theracurmin in patients who underwent mosaicplasty for knee chondral or osteochondral diseases over 12 months of treatment.We enrolled 50 patients, older than 20 years of age, who underwent mosaicplasty for their knee joint diseases. Theracurmin at 180 mg of curcumin per day or placebo was administered orally every day for 12 months. Because 7 patients dropped out of the study, 43 patients were examined; they included 14 men and 29 women and 24 right and 19 left knees. The mean operative age was 59.5 years (range, 24-84 years). We evaluated the Japanese Orthopaedic Association knee osteoarthritis score (JOA), visual analog scale (VAS), and Japanese Knee Osteoarthritis Measure (JKOM) as clinical symptoms; T2 mapping values using magnetic resonance imaging as an indication of the chondroprotective effect; and blood concentration of curcumin at 0, 3, 6, and 12 months after the operations. We performed intraoperative acoustic evaluation of articular cartilage as a measure of chondroprotective effect during the operations and second-look arthroscopy.The JOA, VAS and JKOM at 3, 6, and 12 months were significantly better than those during the preoperative period. However, the values of JOA, VAS and JKOM and T2 mapping were not significantly different between the Theracurmin and placebo groups. The blood concentration of curcumin in the Theracurmin group was significantly higher than that in the placebo group at 3, 6, and 12 months after the operations. Cartilage stiffness and surface roughness were significantly better in the Theracurmin group than in the placebo group at second-look arthroscopy.The oral administration of Theracurmin for 1 year demonstrated significantly better chondroprotective effects and no worse clinical effects and adverse events than the placebo.Level I, double-blinded, placebo-controlled, prospective study." @default.
• W4205865051 created "2022-01-25" @default.
• W4205865051 creator A5012070265 @default.
• W4205865051 creator A5018169932 @default.
• W4205865051 creator A5019825512 @default.
• W4205865051 creator A5030390500 @default.
• W4205865051 creator A5050468448 @default.
• W4205865051 creator A5069517897 @default.
• W4205865051 date "2022-04-01" @default.
• W4205865051 modified "2023-09-26" @default.
• W4205865051 title "The Oral Administration of Highly-Bioavailable Curcumin for One Year Has Clinical and Chondro-Protective Effects: A Randomized, Double-Blinded, Placebo-Controlled Prospective Study" @default.
• W4205865051 cites W1258584912 @default.
• W4205865051 cites W1813628317 @default.
• W4205865051 cites W1847692633 @default.
• W4205865051 cites W1942646272 @default.
• W4205865051 cites W1965307247 @default.
• W4205865051 cites W1969133685 @default.
• W4205865051 cites W1972179974 @default.
• W4205865051 cites W1983341626 @default.
• W4205865051 cites W1986381795 @default.
• W4205865051 cites W2000248590 @default.
• W4205865051 cites W2006253988 @default.
• W4205865051 cites W2013347154 @default.
• W4205865051 cites W2026910871 @default.
• W4205865051 cites W2036711596 @default.
• W4205865051 cites W2037596655 @default.
• W4205865051 cites W2041938357 @default.
• W4205865051 cites W2059556249 @default.
• W4205865051 cites W2071583928 @default.
• W4205865051 cites W2072665589 @default.
• W4205865051 cites W2078908396 @default.
• W4205865051 cites W2084969117 @default.
• W4205865051 cites W2086170145 @default.
• W4205865051 cites W2097527878 @default.
• W4205865051 cites W2100672259 @default.
• W4205865051 cites W2101124639 @default.
• W4205865051 cites W2122207582 @default.
• W4205865051 cites W2130814871 @default.
• W4205865051 cites W2142405038 @default.
• W4205865051 cites W2145887093 @default.
• W4205865051 cites W2419007422 @default.
• W4205865051 cites W2514369987 @default.
• W4205865051 cites W2522712150 @default.
• W4205865051 cites W2626278327 @default.
• W4205865051 cites W2783826729 @default.
• W4205865051 cites W2792692127 @default.
• W4205865051 cites W2804754871 @default.
• W4205865051 cites W2886128255 @default.
• W4205865051 cites W2890029408 @default.
• W4205865051 cites W2919223251 @default.
• W4205865051 cites W2936843542 @default.
• W4205865051 cites W2948674950 @default.
• W4205865051 cites W2965857448 @default.
• W4205865051 cites W2971356356 @default.
• W4205865051 cites W2979118523 @default.
• W4205865051 cites W2997395980 @default.
• W4205865051 cites W3011802173 @default.
• W4205865051 cites W3048444808 @default.
• W4205865051 cites W788622 @default.
• W4205865051 doi "https://doi.org/10.1016/j.asmr.2021.10.016" @default.
• W4205865051 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35494290" @default.
• W4205865051 hasPublicationYear "2022" @default.
• W4205865051 type Work @default.
• W4205865051 citedByCount "3" @default.
• W4205865051 countsByYear W42058650512022 @default.
• W4205865051 countsByYear W42058650512023 @default.
• W4205865051 crossrefType "journal-article" @default.
• W4205865051 hasAuthorship W4205865051A5012070265 @default.
• W4205865051 hasAuthorship W4205865051A5018169932 @default.
• W4205865051 hasAuthorship W4205865051A5019825512 @default.
• W4205865051 hasAuthorship W4205865051A5030390500 @default.
• W4205865051 hasAuthorship W4205865051A5050468448 @default.
• W4205865051 hasAuthorship W4205865051A5069517897 @default.
• W4205865051 hasBestOaLocation W42058650511 @default.
• W4205865051 hasConcept C126322002 @default.
• W4205865051 hasConcept C126838900 @default.
• W4205865051 hasConcept C141071460 @default.
• W4205865051 hasConcept C14184104 @default.
• W4205865051 hasConcept C142724271 @default.
• W4205865051 hasConcept C143409427 @default.
• W4205865051 hasConcept C168563851 @default.
• W4205865051 hasConcept C204787440 @default.
• W4205865051 hasConcept C27081682 @default.
• W4205865051 hasConcept C2776164576 @default.
• W4205865051 hasConcept C2778250585 @default.
• W4205865051 hasConcept C535046627 @default.
• W4205865051 hasConcept C71924100 @default.
• W4205865051 hasConcept C98274493 @default.
• W4205865051 hasConceptScore W4205865051C126322002 @default.
• W4205865051 hasConceptScore W4205865051C126838900 @default.
• W4205865051 hasConceptScore W4205865051C141071460 @default.
• W4205865051 hasConceptScore W4205865051C14184104 @default.
• W4205865051 hasConceptScore W4205865051C142724271 @default.
• W4205865051 hasConceptScore W4205865051C143409427 @default.
• W4205865051 hasConceptScore W4205865051C168563851 @default.
• W4205865051 hasConceptScore W4205865051C204787440 @default.
• W4205865051 hasConceptScore W4205865051C27081682 @default.
• W4205865051 hasConceptScore W4205865051C2776164576 @default.

• next